The financial impact of cancer on the individual patient is often characterised as an objective and a subjective financial burden. The objective financial burden gives no information on how the patient himself perceives the financial impact and the consequences on his life; this view is provided by the subjective financial burden, which describes the impact and consequences of the objective costs on the patient. This often results in material consequences, psychological effects, or behavioural changes, which then are expressed as a “financial toxicity”. The currently existing tools are either only narrowly validated, are generic economic tools, are restricted to a certain health care system, are restricted to a specific cancer site, or do not cover all relevant domains of financial toxicity.
The aim of this Phase I study is to develop a list of issues related to financial toxicity in cancer patients. This Phase I study will result in an evidence-based decision about the appropriateness of a full module versus add-on items for financial toxicity and a final, comprehensive list of issues to be included in Phase 2, regardless of whether Phase 2 is a full module or add-on items.
The usual EORTC Quality of Life Group steps for Phase I development of a QLG module will be followed. This includes evaluation of the financial issues relevant for cancer patients through a systematic literature review and interviews with patients and care providers and the creation of a final issue list
- Finalization of the study protocol
- Title and abstract screening+ full text screening completed
- Ethics approval obtained (for PI site, Germany)
- Literature review at the issue extraction phase.
- Enrolment for qualitative reviews about to start.
- Collaborators in countries where little to no literature on fancial toxicities in cancer patients exists will conduct qualitative interviews with cancer patients.
- A list of issues will be created based on the literature review and the qualitative interviews.
- Please see below for expected timelines.
The aim of this project is to develop a questionnaire which measures the financial toxicity/subjective financial burden of cancer patients.